KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $7.4 million.

  • GoodRx Holdings' Other Working Capital Changes rose 1829.17% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 6815.22%. This contributed to the annual value of -$6.3 million for FY2024, which is 11967.23% down from last year.
  • Per GoodRx Holdings' latest filing, its Other Working Capital Changes stood at $7.4 million for Q3 2025, which was up 1829.17% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Other Working Capital Changes ranged from a high of $37.4 million in Q2 2021 and a low of -$52.9 million during Q3 2021
  • Moreover, its 5-year median value for Other Working Capital Changes was $6.3 million (2024), whereas its average is $2.4 million.
  • In the last 5 years, GoodRx Holdings' Other Working Capital Changes surged by 320654.29% in 2021 and then tumbled by 91023.97% in 2024.
  • GoodRx Holdings' Other Working Capital Changes (Quarter) stood at -$11.4 million in 2021, then skyrocketed by 192.46% to $10.5 million in 2022, then tumbled by 78.16% to $2.3 million in 2023, then plummeted by 910.24% to -$18.6 million in 2024, then skyrocketed by 139.99% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, $2.3 million for Q2 2025, and $13.5 million during Q1 2025.